Overview

Our History

Leadership Team

Partner

Portfolio Advisory Board

Peer Reviewed Publications

Announcements and Circulars

Listing Documents

Investor Presentation

IR Contact

Investor Calendar

Stock Information (2552.HK)

Corporate Communications

Our Science

Peer Reviewed Publications

Presentations

2025 CDS

多格列艾汀对胰岛α细胞胰高糖素和GLP-1分泌的调节作用（2025 CDS）

2025 CDS

亚洲不同程度糖耐量受损人群的β细胞功能特征及多格列艾汀单次给药的影响（2025 CDS）

2024 ADA Poster

Effect of Dorzagliatin, a Dual-Acting Glucokinase Activator, on Insulin and Glucagon Secretion in Impaired and Normal Glucose Tolerance

2024 ADA Poster

The Effects of the Combination of Dorzagliatin and Canagliflozin on Glucose Homeostasis in Mice

2024 ADA Poster

The Effects of SGLT2 Inhibitor Canagliflozin on Glucagon Secretion in SUR1 Knockout Mice

2023 ADA Poster

Accessing Glucose Fluctuation—The Role of FPG, PPG, and HbA1c

About Us

Overview

Our History

Leadership Team

Portfolio Advisory Board

Partner

Media center

Research & Development

Inovation

Dorzagliatin

mGluR5

Presentations

Peer Reviewed Publications

Media

Company News

Media Releases

Video

Investor Relations

Corporate Governance

Financial Report

Announcements & Circulars

Listing Documents

Investor Presentation

IR Contact

Investor Calendar

Stock information

Careers

Culture

Join Us

Products&Pipeline

Pipeline

HuaTangNing(华堂宁®)

Focus Us

沪公网安备 31011502013809号 Privacy Statement Terms of Use

How we use cookies

Hua Medicine uses cookies to enable and improve the use of the website. By continuing to use the site, you consent to the use of these cookies. To learn more about cookies, please read our privacy statement.